Regis vs PetMed Express

Regis and PetMed Express are presented here to help readers understand how each business operates, how strategies relate to outcomes, and the market context in which they compete. This page compares business models, financial performance, and market context in a neutral, accessible way. Educational content, not financial advice.

Comparison Snapshot

Key Financial Metrics

RGS

Metric

PETS

$59.06M

Market Cap

$70.31M

N/A

Potential Profit

-17.91%

N/A

Analyst Rating

Sell

Investment Analysis

Regis

RGS

Pros

Regis Corp. showed revenue growth to $210.13 million in fiscal 2025, increasing 3.52% year-over-year, indicating a positive sales momentum.
The company has a low price-to-earnings ratio of 0.61, suggesting potential undervaluation relative to earnings.
Analysts project strong long-term price appreciation for Regis stock, with forecasts exceeding 500% growth by 2040-2050.

Considerations

Recent technical signals indicate a negative short- and long-term outlook with ongoing sell signals and potential for further price declines.
Regis exhibits higher than average stock price volatility with a beta of 1.47, exposing investors to increased market risk.
Revenue has shown some volatility with a 4.88% decline in the last twelve months and inconsistent quarterly growth trends.

PetMed Express

PETS

Pros

PetMed Express offers a high dividend yield near 14%, providing strong income potential for investors.
The company operates in the niche pet pharmaceutical market, catering to growing direct-to-consumer demand for pet medications and health products.
Recent leadership additions to the board signal potential governance improvements and strategic direction clarity.

Considerations

PetMed Express has a high price-to-earnings ratio around 57, indicating expensive valuation relative to earnings.
The stock price has experienced a wide 52-week range, suggesting considerable recent price instability and market uncertainty.
The company’s smaller market cap and employee base highlight potential limitations in scale and operational leverage compared to larger competitors.

About The Companies

Regis (RGS)

Regis Corporation is a prominent player in the haircare industry, primarily operating through a franchise-based business model. The company franchises, owns, and holds interests in thousands of beauty salons and cosmetology schools across the world, including in the United States, Canada, and Puerto Rico. Its portfolio of well-known salon brands includes names like Supercuts, SmartStyle, Cost Cutters, and Roosters. Regis provides comprehensive support to its franchisees, covering everything from business training and stylist education to marketing and site selection. Its business is divided into two main segments: Franchise salons and Company-owned salons, with a growing emphasis on the franchise side. This model allows the company to generate revenue from royalties and fees while offering a wide range of haircare services and professional products to consumers. As with any investment, the value can go down as well as up.

PetMed Express (PETS)

PetMed Express, trading as PETS, is a small-cap online pet pharmacy that sells prescription and over-the-counter medications, nutritional supplements and pet care products primarily in the US. The business operates an e-commerce platform and direct-to-consumer fulfilment, leveraging brand recognition built around the 1-800-PetMeds name. Investors should note the company’s modest market capitalisation (about $55.7m), which can mean lower liquidity and higher share price volatility compared with larger peers. Revenue drivers include repeat prescriptions and private-label products, while margins depend on sourcing, shipping costs and competitive pricing. Key risks include regulatory oversight of veterinary medicines, competition from larger retail and online players, and concentration of sales channels. For those considering PETS, view it as speculative and research operational performance, cash flow and regulatory developments carefully. This information is general and educational only, not personalised investment advice; values can fall as well as rise, so assess suitability for your circumstances.

Which Baskets Do They Appear In?

No baskets available in this category

Which Baskets Do They Appear In?

No baskets available in this category

Buy RGS or PETS in Nemo

🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Comparisons

Regis vs Veru

Regis vs Veru: comparing business models and outlook

Regis vs TDH

Regis vs TDH: A comparison of business models

Regis vs PetMed Express

Comparison Snapshot